Key Drivers
- Low leverage
- High FCF
- Large SG&A
AIAI Summary
Inspire has transitioned from a high‑growth multiple call to a cash‑driven commercialization and margin‑conversion story—investors should now treat the equity as a defensive value play that needs clear evidence of sustained SG&A per‑implant reduction and flawless Inspire V supply/reimbursement execution to re‑rate. The key risk is legal/governance escalation (potential settlements, injunctions, or distracted management) that could erode the cash cushion and derail margin conversion, so monitor legal developments, weekly implant cadence, and SG&A trajectory closely.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Low leverage
- •High FCF
- •Large SG&A
Strong balance sheet and cash-generation (low leverage, high cash and FCF) offset by outsized operating expenses that compress margins and create volatility.
Price Behavior
Key Price Behavior Insights:
- •Strong downside momentum
- •Support at low
- •Resistance cluster
INSP is in a clear short-term downtrend—down ~21–22% from $68.05 to $53.72 over the last month, trading well below the ~$60 21-day SMA with immediate support at $53.72 and resistance in the $59–65 band, where a break below support would deepen the bearish case while a reclaim above ~$60 would be the first sign of reversal.
Rapid ~21–22% decline from $68.05 to $53.72 over the last month indicating elevated short-term volatility
Sentiment & News
Key News Insights:
- •Strong Q4/results
- •Analyst volatility
- •Governance probe
Inspire Medical saw mixed March 2026 signals—solid operational updates and investor outreach offset by analyst volatility, a shareholder stake sell-down and a governance investigation.
The mix of positive operational progress and investor engagement is tempered by regulatory and ownership concerns, likely keeping INSP shares volatile until clarity on the investigation and reimbursement/competitive risks emerges
Similar Companies in Healthcare
Other companies in the same sector with AI ratings